nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—CA4—epilepsy syndrome	0.328	1	CbGaD
Methyclothiazide—CA1—Lacosamide—epilepsy syndrome	0.0591	0.128	CbGbCtD
Methyclothiazide—CA4—Lacosamide—epilepsy syndrome	0.0556	0.12	CbGbCtD
Methyclothiazide—CA2—Lacosamide—epilepsy syndrome	0.0511	0.111	CbGbCtD
Methyclothiazide—CA1—Acetazolamide—epilepsy syndrome	0.0407	0.088	CbGbCtD
Methyclothiazide—CA4—Acetazolamide—epilepsy syndrome	0.0382	0.0827	CbGbCtD
Methyclothiazide—CA1—Zonisamide—epilepsy syndrome	0.0376	0.0814	CbGbCtD
Methyclothiazide—CA4—Zonisamide—epilepsy syndrome	0.0354	0.0766	CbGbCtD
Methyclothiazide—CA2—Acetazolamide—epilepsy syndrome	0.0352	0.0761	CbGbCtD
Methyclothiazide—CA2—Zonisamide—epilepsy syndrome	0.0325	0.0704	CbGbCtD
Methyclothiazide—CA1—Topiramate—epilepsy syndrome	0.0274	0.0593	CbGbCtD
Methyclothiazide—CA4—Topiramate—epilepsy syndrome	0.0258	0.0558	CbGbCtD
Methyclothiazide—CA2—Topiramate—epilepsy syndrome	0.0237	0.0513	CbGbCtD
Methyclothiazide—SLC12A1—ganglion—epilepsy syndrome	0.00244	0.115	CbGeAlD
Methyclothiazide—CA4—ganglion—epilepsy syndrome	0.00132	0.062	CbGeAlD
Methyclothiazide—SLC12A1—forebrain—epilepsy syndrome	0.00103	0.0484	CbGeAlD
Methyclothiazide—CA4—hindbrain—epilepsy syndrome	0.000997	0.0471	CbGeAlD
Methyclothiazide—SLC12A1—telencephalon—epilepsy syndrome	0.000943	0.0445	CbGeAlD
Methyclothiazide—CA2—hindbrain—epilepsy syndrome	0.000827	0.039	CbGeAlD
Methyclothiazide—CA1—forebrain—epilepsy syndrome	0.000706	0.0333	CbGeAlD
Methyclothiazide—SLC12A1—spinal cord—epilepsy syndrome	0.000661	0.0312	CbGeAlD
Methyclothiazide—CA1—telencephalon—epilepsy syndrome	0.000649	0.0306	CbGeAlD
Methyclothiazide—Quinethazone—SLC12A2—epilepsy syndrome	0.000642	0.171	CrCbGaD
Methyclothiazide—SLC12A1—head—epilepsy syndrome	0.000587	0.0277	CbGeAlD
Methyclothiazide—CA4—brainstem—epilepsy syndrome	0.000572	0.027	CbGeAlD
Methyclothiazide—SLC12A1—nervous system—epilepsy syndrome	0.000557	0.0263	CbGeAlD
Methyclothiazide—CA4—forebrain—epilepsy syndrome	0.000552	0.026	CbGeAlD
Methyclothiazide—SLC12A1—central nervous system—epilepsy syndrome	0.000536	0.0253	CbGeAlD
Methyclothiazide—CA4—telencephalon—epilepsy syndrome	0.000507	0.0239	CbGeAlD
Methyclothiazide—CA2—brainstem—epilepsy syndrome	0.000474	0.0224	CbGeAlD
Methyclothiazide—CA2—forebrain—epilepsy syndrome	0.000457	0.0216	CbGeAlD
Methyclothiazide—CA1—spinal cord—epilepsy syndrome	0.000455	0.0215	CbGeAlD
Methyclothiazide—SLC12A1—brain—epilepsy syndrome	0.000426	0.0201	CbGeAlD
Methyclothiazide—CA2—telencephalon—epilepsy syndrome	0.000421	0.0198	CbGeAlD
Methyclothiazide—CA1—head—epilepsy syndrome	0.000404	0.0191	CbGeAlD
Methyclothiazide—CA4—medulla oblongata—epilepsy syndrome	0.000399	0.0188	CbGeAlD
Methyclothiazide—CA1—nervous system—epilepsy syndrome	0.000383	0.0181	CbGeAlD
Methyclothiazide—CA1—central nervous system—epilepsy syndrome	0.000369	0.0174	CbGeAlD
Methyclothiazide—CA4—midbrain—epilepsy syndrome	0.000364	0.0172	CbGeAlD
Methyclothiazide—Metolazone—CA4—epilepsy syndrome	0.000362	0.0964	CrCbGaD
Methyclothiazide—CA4—spinal cord—epilepsy syndrome	0.000355	0.0168	CbGeAlD
Methyclothiazide—Hydroflumethiazide—KCNMA1—epilepsy syndrome	0.000338	0.0901	CrCbGaD
Methyclothiazide—CA2—medulla oblongata—epilepsy syndrome	0.000331	0.0156	CbGeAlD
Methyclothiazide—Hydrochlorothiazide—KCNMA1—epilepsy syndrome	0.000329	0.0876	CrCbGaD
Methyclothiazide—Cyclothiazide—CA4—epilepsy syndrome	0.000327	0.0872	CrCbGaD
Methyclothiazide—Benzthiazide—CA4—epilepsy syndrome	0.000327	0.0872	CrCbGaD
Methyclothiazide—Chlorothiazide—CA4—epilepsy syndrome	0.000325	0.0865	CrCbGaD
Methyclothiazide—Diclofenamide—CA4—epilepsy syndrome	0.000325	0.0865	CrCbGaD
Methyclothiazide—CA4—head—epilepsy syndrome	0.000316	0.0149	CbGeAlD
Methyclothiazide—CA2—midbrain—epilepsy syndrome	0.000302	0.0143	CbGeAlD
Methyclothiazide—CA4—nervous system—epilepsy syndrome	0.0003	0.0141	CbGeAlD
Methyclothiazide—CA2—spinal cord—epilepsy syndrome	0.000295	0.0139	CbGeAlD
Methyclothiazide—CA1—brain—epilepsy syndrome	0.000293	0.0138	CbGeAlD
Methyclothiazide—CA4—central nervous system—epilepsy syndrome	0.000288	0.0136	CbGeAlD
Methyclothiazide—CA4—cerebellum—epilepsy syndrome	0.000282	0.0133	CbGeAlD
Methyclothiazide—Hydroflumethiazide—CA4—epilepsy syndrome	0.000274	0.0731	CrCbGaD
Methyclothiazide—Hydrochlorothiazide—CA4—epilepsy syndrome	0.000267	0.0711	CrCbGaD
Methyclothiazide—CA2—head—epilepsy syndrome	0.000262	0.0124	CbGeAlD
Methyclothiazide—CA2—nervous system—epilepsy syndrome	0.000248	0.0117	CbGeAlD
Methyclothiazide—CA2—central nervous system—epilepsy syndrome	0.000239	0.0113	CbGeAlD
Methyclothiazide—Trichlormethiazide—CA4—epilepsy syndrome	0.000238	0.0633	CrCbGaD
Methyclothiazide—CA2—cerebellum—epilepsy syndrome	0.000234	0.011	CbGeAlD
Methyclothiazide—CA4—brain—epilepsy syndrome	0.000229	0.0108	CbGeAlD
Methyclothiazide—CA2—brain—epilepsy syndrome	0.00019	0.00896	CbGeAlD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000139	0.00184	CbGpPWpGaD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000137	0.00181	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000134	0.00177	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000128	0.0017	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000127	0.00168	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000127	0.00168	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000127	0.00168	CbGpPWpGaD
Methyclothiazide—Malnutrition—Valproic Acid—epilepsy syndrome	0.000125	0.00114	CcSEcCtD
Methyclothiazide—Paraesthesia—Phenytoin—epilepsy syndrome	0.000125	0.00114	CcSEcCtD
Methyclothiazide—Constipation—Zonisamide—epilepsy syndrome	0.000124	0.00113	CcSEcCtD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000124	0.00165	CbGpPWpGaD
Methyclothiazide—Urticaria—Vigabatrin—epilepsy syndrome	0.000124	0.00113	CcSEcCtD
Methyclothiazide—Hypersensitivity—Midazolam—epilepsy syndrome	0.000123	0.00113	CcSEcCtD
Methyclothiazide—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000123	0.00112	CcSEcCtD
Methyclothiazide—Nausea—Clobazam—epilepsy syndrome	0.000123	0.00112	CcSEcCtD
Methyclothiazide—Asthenia—Propofol—epilepsy syndrome	0.000123	0.00112	CcSEcCtD
Methyclothiazide—Erythema multiforme—Pregabalin—epilepsy syndrome	0.000123	0.00112	CcSEcCtD
Methyclothiazide—Pancreatitis—Topiramate—epilepsy syndrome	0.000123	0.00112	CcSEcCtD
Methyclothiazide—Anorexia—Lamotrigine—epilepsy syndrome	0.000122	0.00112	CcSEcCtD
Methyclothiazide—Dizziness—Acetazolamide—epilepsy syndrome	0.000122	0.00111	CcSEcCtD
Methyclothiazide—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000122	0.00111	CcSEcCtD
Methyclothiazide—Urticaria—Diazepam—epilepsy syndrome	0.000122	0.00111	CcSEcCtD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000122	0.00161	CbGpPWpGaD
Methyclothiazide—Decreased appetite—Clonazepam—epilepsy syndrome	0.000122	0.00111	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000121	0.00161	CbGpPWpGaD
Methyclothiazide—Decreased appetite—Phenytoin—epilepsy syndrome	0.000121	0.0011	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000121	0.0016	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000121	0.0016	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—HES1—epilepsy syndrome	0.000121	0.0016	CbGpPWpGaD
Methyclothiazide—Asthenia—Midazolam—epilepsy syndrome	0.00012	0.0011	CcSEcCtD
Methyclothiazide—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.00012	0.0011	CcSEcCtD
Methyclothiazide—Muscle spasms—Valproic Acid—epilepsy syndrome	0.00012	0.0011	CcSEcCtD
Methyclothiazide—Constipation—Clonazepam—epilepsy syndrome	0.00012	0.00109	CcSEcCtD
Methyclothiazide—Paraesthesia—Carbamazepine—epilepsy syndrome	0.000119	0.00109	CcSEcCtD
Methyclothiazide—Constipation—Phenytoin—epilepsy syndrome	0.000119	0.00108	CcSEcCtD
Methyclothiazide—Asthenia—Levetiracetam—epilepsy syndrome	0.000119	0.00108	CcSEcCtD
Methyclothiazide—Constipation—Oxcarbazepine—epilepsy syndrome	0.000118	0.00108	CcSEcCtD
Methyclothiazide—Urticaria—Felbamate—epilepsy syndrome	0.000118	0.00108	CcSEcCtD
Methyclothiazide—Vision blurred—Valproic Acid—epilepsy syndrome	0.000118	0.00107	CcSEcCtD
Methyclothiazide—Body temperature increased—Felbamate—epilepsy syndrome	0.000117	0.00107	CcSEcCtD
Methyclothiazide—Vomiting—Acetazolamide—epilepsy syndrome	0.000117	0.00107	CcSEcCtD
Methyclothiazide—Diarrhoea—Propofol—epilepsy syndrome	0.000117	0.00107	CcSEcCtD
Methyclothiazide—Headache—Acetazolamide—epilepsy syndrome	0.000116	0.00105	CcSEcCtD
Methyclothiazide—Urticaria—Zonisamide—epilepsy syndrome	0.000115	0.00105	CcSEcCtD
Methyclothiazide—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000115	0.00105	CcSEcCtD
Methyclothiazide—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000115	0.00105	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000115	0.00153	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000115	0.00153	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000115	0.00153	CbGpPWpGaD
Methyclothiazide—Body temperature increased—Zonisamide—epilepsy syndrome	0.000115	0.00105	CcSEcCtD
Methyclothiazide—Agitation—Valproic Acid—epilepsy syndrome	0.000115	0.00105	CcSEcCtD
Methyclothiazide—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000115	0.00105	CcSEcCtD
Methyclothiazide—Asthenia—Fosphenytoin—epilepsy syndrome	0.000115	0.00105	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Topiramate—epilepsy syndrome	0.000114	0.00104	CcSEcCtD
Methyclothiazide—Constipation—Carbamazepine—epilepsy syndrome	0.000113	0.00104	CcSEcCtD
Methyclothiazide—Dizziness—Propofol—epilepsy syndrome	0.000113	0.00103	CcSEcCtD
Methyclothiazide—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000113	0.00103	CcSEcCtD
Methyclothiazide—Hypersensitivity—Diazepam—epilepsy syndrome	0.000113	0.00103	CcSEcCtD
Methyclothiazide—Malnutrition—Pregabalin—epilepsy syndrome	0.000113	0.00103	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000113	0.00103	CcSEcCtD
Methyclothiazide—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000112	0.00103	CcSEcCtD
Methyclothiazide—Vertigo—Valproic Acid—epilepsy syndrome	0.000112	0.00102	CcSEcCtD
Methyclothiazide—Pneumonia—Topiramate—epilepsy syndrome	0.000112	0.00102	CcSEcCtD
Methyclothiazide—Leukopenia—Valproic Acid—epilepsy syndrome	0.000112	0.00102	CcSEcCtD
Methyclothiazide—Asthenia—Vigabatrin—epilepsy syndrome	0.000112	0.00102	CcSEcCtD
Methyclothiazide—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000112	0.00102	CcSEcCtD
Methyclothiazide—Urticaria—Clonazepam—epilepsy syndrome	0.000111	0.00101	CcSEcCtD
Methyclothiazide—Dizziness—Midazolam—epilepsy syndrome	0.000111	0.00101	CcSEcCtD
Methyclothiazide—Body temperature increased—Clonazepam—epilepsy syndrome	0.000111	0.00101	CcSEcCtD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000111	0.00147	CbGpPWpGaD
Methyclothiazide—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.000111	0.00101	CcSEcCtD
Methyclothiazide—Urticaria—Phenytoin—epilepsy syndrome	0.00011	0.00101	CcSEcCtD
Methyclothiazide—Asthenia—Diazepam—epilepsy syndrome	0.00011	0.001	CcSEcCtD
Methyclothiazide—Body temperature increased—Phenytoin—epilepsy syndrome	0.00011	0.001	CcSEcCtD
Methyclothiazide—Urticaria—Oxcarbazepine—epilepsy syndrome	0.00011	0.001	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.00011	0.00146	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.00011	0.00146	CbGpPWpGaD
Methyclothiazide—Constipation—Lamotrigine—epilepsy syndrome	0.00011	0.001	CcSEcCtD
Methyclothiazide—Nausea—Acetazolamide—epilepsy syndrome	0.00011	0.000999	CcSEcCtD
Methyclothiazide—Dizziness—Levetiracetam—epilepsy syndrome	0.000109	0.000998	CcSEcCtD
Methyclothiazide—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000109	0.000997	CcSEcCtD
Methyclothiazide—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000109	0.000997	CcSEcCtD
Methyclothiazide—Vomiting—Propofol—epilepsy syndrome	0.000109	0.000994	CcSEcCtD
Methyclothiazide—Muscle spasms—Pregabalin—epilepsy syndrome	0.000109	0.00099	CcSEcCtD
Methyclothiazide—Rash—Propofol—epilepsy syndrome	0.000108	0.000985	CcSEcCtD
Methyclothiazide—Dermatitis—Propofol—epilepsy syndrome	0.000108	0.000984	CcSEcCtD
Methyclothiazide—Headache—Propofol—epilepsy syndrome	0.000107	0.000979	CcSEcCtD
Methyclothiazide—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000107	0.000976	CcSEcCtD
Methyclothiazide—Vomiting—Midazolam—epilepsy syndrome	0.000107	0.000972	CcSEcCtD
Methyclothiazide—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000107	0.000972	CcSEcCtD
Methyclothiazide—Asthenia—Felbamate—epilepsy syndrome	0.000106	0.000971	CcSEcCtD
Methyclothiazide—Vision blurred—Pregabalin—epilepsy syndrome	0.000106	0.000971	CcSEcCtD
Methyclothiazide—Rash—Midazolam—epilepsy syndrome	0.000106	0.000964	CcSEcCtD
Methyclothiazide—Dizziness—Fosphenytoin—epilepsy syndrome	0.000106	0.000964	CcSEcCtD
Methyclothiazide—Dermatitis—Midazolam—epilepsy syndrome	0.000106	0.000963	CcSEcCtD
Methyclothiazide—Urticaria—Carbamazepine—epilepsy syndrome	0.000105	0.000962	CcSEcCtD
Methyclothiazide—Vomiting—Levetiracetam—epilepsy syndrome	0.000105	0.00096	CcSEcCtD
Methyclothiazide—Headache—Midazolam—epilepsy syndrome	0.000105	0.000958	CcSEcCtD
Methyclothiazide—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000105	0.000957	CcSEcCtD
Methyclothiazide—Diarrhoea—Diazepam—epilepsy syndrome	0.000105	0.000957	CcSEcCtD
Methyclothiazide—Rash—Levetiracetam—epilepsy syndrome	0.000104	0.000952	CcSEcCtD
Methyclothiazide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000104	0.000951	CcSEcCtD
Methyclothiazide—Asthenia—Zonisamide—epilepsy syndrome	0.000104	0.000951	CcSEcCtD
Methyclothiazide—Agranulocytosis—Topiramate—epilepsy syndrome	0.000104	0.000949	CcSEcCtD
Methyclothiazide—Agitation—Pregabalin—epilepsy syndrome	0.000104	0.000946	CcSEcCtD
Methyclothiazide—Headache—Levetiracetam—epilepsy syndrome	0.000104	0.000946	CcSEcCtD
Methyclothiazide—Malnutrition—Gabapentin—epilepsy syndrome	0.000104	0.000944	CcSEcCtD
Methyclothiazide—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000103	0.000941	CcSEcCtD
Methyclothiazide—Dizziness—Vigabatrin—epilepsy syndrome	0.000103	0.000939	CcSEcCtD
Methyclothiazide—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000102	0.000934	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000102	0.00093	CcSEcCtD
Methyclothiazide—Urticaria—Lamotrigine—epilepsy syndrome	0.000102	0.00093	CcSEcCtD
Methyclothiazide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000102	0.00093	CcSEcCtD
Methyclothiazide—Nausea—Propofol—epilepsy syndrome	0.000102	0.000928	CcSEcCtD
Methyclothiazide—Vomiting—Fosphenytoin—epilepsy syndrome	0.000102	0.000927	CcSEcCtD
Methyclothiazide—Diarrhoea—Felbamate—epilepsy syndrome	0.000102	0.000926	CcSEcCtD
Methyclothiazide—Vertigo—Pregabalin—epilepsy syndrome	0.000101	0.000925	CcSEcCtD
Methyclothiazide—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000101	0.000925	CcSEcCtD
Methyclothiazide—Dizziness—Diazepam—epilepsy syndrome	0.000101	0.000925	CcSEcCtD
Methyclothiazide—Leukopenia—Pregabalin—epilepsy syndrome	0.000101	0.000922	CcSEcCtD
Methyclothiazide—Rash—Fosphenytoin—epilepsy syndrome	0.000101	0.000919	CcSEcCtD
Methyclothiazide—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000101	0.000918	CcSEcCtD
Methyclothiazide—Asthenia—Clonazepam—epilepsy syndrome	0.0001	0.000916	CcSEcCtD
Methyclothiazide—Headache—Fosphenytoin—epilepsy syndrome	0.0001	0.000913	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	9.98e-05	0.00091	CcSEcCtD
Methyclothiazide—Asthenia—Phenytoin—epilepsy syndrome	9.98e-05	0.00091	CcSEcCtD
Methyclothiazide—Nausea—Midazolam—epilepsy syndrome	9.96e-05	0.000908	CcSEcCtD
Methyclothiazide—Muscle spasms—Gabapentin—epilepsy syndrome	9.95e-05	0.000908	CcSEcCtD
Methyclothiazide—Diarrhoea—Zonisamide—epilepsy syndrome	9.94e-05	0.000907	CcSEcCtD
Methyclothiazide—Asthenia—Oxcarbazepine—epilepsy syndrome	9.92e-05	0.000905	CcSEcCtD
Methyclothiazide—Vomiting—Vigabatrin—epilepsy syndrome	9.9e-05	0.000903	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	9.85e-05	0.00131	CbGpPWpGaD
Methyclothiazide—Nausea—Levetiracetam—epilepsy syndrome	9.83e-05	0.000897	CcSEcCtD
Methyclothiazide—Rash—Vigabatrin—epilepsy syndrome	9.82e-05	0.000896	CcSEcCtD
Methyclothiazide—Dizziness—Felbamate—epilepsy syndrome	9.81e-05	0.000895	CcSEcCtD
Methyclothiazide—Dermatitis—Vigabatrin—epilepsy syndrome	9.81e-05	0.000895	CcSEcCtD
Methyclothiazide—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.78e-05	0.000892	CcSEcCtD
Methyclothiazide—Vision blurred—Gabapentin—epilepsy syndrome	9.76e-05	0.00089	CcSEcCtD
Methyclothiazide—Headache—Vigabatrin—epilepsy syndrome	9.76e-05	0.00089	CcSEcCtD
Methyclothiazide—Vomiting—Diazepam—epilepsy syndrome	9.75e-05	0.000889	CcSEcCtD
Methyclothiazide—Anorexia—Valproic Acid—epilepsy syndrome	9.72e-05	0.000886	CcSEcCtD
Methyclothiazide—Rash—Diazepam—epilepsy syndrome	9.67e-05	0.000882	CcSEcCtD
Methyclothiazide—Dermatitis—Diazepam—epilepsy syndrome	9.66e-05	0.000881	CcSEcCtD
Methyclothiazide—Dizziness—Zonisamide—epilepsy syndrome	9.6e-05	0.000876	CcSEcCtD
Methyclothiazide—Headache—Diazepam—epilepsy syndrome	9.6e-05	0.000876	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	9.6e-05	0.00127	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	9.6e-05	0.00127	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Clonazepam—epilepsy syndrome	9.58e-05	0.000874	CcSEcCtD
Methyclothiazide—Asthenia—Carbamazepine—epilepsy syndrome	9.52e-05	0.000869	CcSEcCtD
Methyclothiazide—Agitation—Gabapentin—epilepsy syndrome	9.51e-05	0.000868	CcSEcCtD
Methyclothiazide—Diarrhoea—Phenytoin—epilepsy syndrome	9.51e-05	0.000868	CcSEcCtD
Methyclothiazide—Nausea—Fosphenytoin—epilepsy syndrome	9.49e-05	0.000866	CcSEcCtD
Methyclothiazide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.46e-05	0.000863	CcSEcCtD
Methyclothiazide—Erythema multiforme—Topiramate—epilepsy syndrome	9.46e-05	0.000863	CcSEcCtD
Methyclothiazide—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.45e-05	0.000862	CcSEcCtD
Methyclothiazide—Vomiting—Felbamate—epilepsy syndrome	9.43e-05	0.000861	CcSEcCtD
Methyclothiazide—Rash—Felbamate—epilepsy syndrome	9.36e-05	0.000853	CcSEcCtD
Methyclothiazide—Dermatitis—Felbamate—epilepsy syndrome	9.35e-05	0.000853	CcSEcCtD
Methyclothiazide—Vertigo—Gabapentin—epilepsy syndrome	9.3e-05	0.000849	CcSEcCtD
Methyclothiazide—Headache—Felbamate—epilepsy syndrome	9.3e-05	0.000848	CcSEcCtD
Methyclothiazide—Leukopenia—Gabapentin—epilepsy syndrome	9.27e-05	0.000845	CcSEcCtD
Methyclothiazide—Dizziness—Clonazepam—epilepsy syndrome	9.26e-05	0.000844	CcSEcCtD
Methyclothiazide—Nausea—Vigabatrin—epilepsy syndrome	9.25e-05	0.000844	CcSEcCtD
Methyclothiazide—Vomiting—Zonisamide—epilepsy syndrome	9.23e-05	0.000842	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Pregabalin—epilepsy syndrome	9.21e-05	0.000841	CcSEcCtD
Methyclothiazide—Asthenia—Lamotrigine—epilepsy syndrome	9.2e-05	0.00084	CcSEcCtD
Methyclothiazide—Dizziness—Phenytoin—epilepsy syndrome	9.19e-05	0.000839	CcSEcCtD
Methyclothiazide—Rash—Zonisamide—epilepsy syndrome	9.16e-05	0.000835	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	9.16e-05	0.00121	CbGpPWpGaD
Methyclothiazide—Paraesthesia—Valproic Acid—epilepsy syndrome	9.15e-05	0.000835	CcSEcCtD
Methyclothiazide—Dermatitis—Zonisamide—epilepsy syndrome	9.15e-05	0.000835	CcSEcCtD
Methyclothiazide—Dizziness—Oxcarbazepine—epilepsy syndrome	9.15e-05	0.000834	CcSEcCtD
Methyclothiazide—Nausea—Diazepam—epilepsy syndrome	9.11e-05	0.000831	CcSEcCtD
Methyclothiazide—Headache—Zonisamide—epilepsy syndrome	9.1e-05	0.00083	CcSEcCtD
Methyclothiazide—Diarrhoea—Carbamazepine—epilepsy syndrome	9.08e-05	0.000828	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Pregabalin—epilepsy syndrome	9.02e-05	0.000823	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—APOD—epilepsy syndrome	8.94e-05	0.00119	CbGpPWpGaD
Methyclothiazide—Vomiting—Clonazepam—epilepsy syndrome	8.9e-05	0.000812	CcSEcCtD
Methyclothiazide—Decreased appetite—Valproic Acid—epilepsy syndrome	8.86e-05	0.000808	CcSEcCtD
Methyclothiazide—Vomiting—Phenytoin—epilepsy syndrome	8.84e-05	0.000806	CcSEcCtD
Methyclothiazide—Rash—Clonazepam—epilepsy syndrome	8.83e-05	0.000805	CcSEcCtD
Methyclothiazide—Dermatitis—Clonazepam—epilepsy syndrome	8.82e-05	0.000804	CcSEcCtD
Methyclothiazide—Nausea—Felbamate—epilepsy syndrome	8.81e-05	0.000804	CcSEcCtD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	8.8e-05	0.00117	CbGpPWpGaD
Methyclothiazide—Vomiting—Oxcarbazepine—epilepsy syndrome	8.79e-05	0.000802	CcSEcCtD
Methyclothiazide—Anorexia—Pregabalin—epilepsy syndrome	8.78e-05	0.000801	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	8.78e-05	0.00116	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	8.78e-05	0.00116	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	8.78e-05	0.00116	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	8.78e-05	0.00116	CbGpPWpGaD
Methyclothiazide—Dizziness—Carbamazepine—epilepsy syndrome	8.78e-05	0.000801	CcSEcCtD
Methyclothiazide—Diarrhoea—Lamotrigine—epilepsy syndrome	8.78e-05	0.000801	CcSEcCtD
Methyclothiazide—Headache—Clonazepam—epilepsy syndrome	8.77e-05	0.0008	CcSEcCtD
Methyclothiazide—Rash—Phenytoin—epilepsy syndrome	8.77e-05	0.0008	CcSEcCtD
Methyclothiazide—Dermatitis—Phenytoin—epilepsy syndrome	8.76e-05	0.000799	CcSEcCtD
Methyclothiazide—Rash—Oxcarbazepine—epilepsy syndrome	8.72e-05	0.000795	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	8.72e-05	0.00116	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	8.72e-05	0.00116	CbGpPWpGaD
Methyclothiazide—Constipation—Valproic Acid—epilepsy syndrome	8.72e-05	0.000795	CcSEcCtD
Methyclothiazide—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.71e-05	0.000795	CcSEcCtD
Methyclothiazide—Headache—Phenytoin—epilepsy syndrome	8.71e-05	0.000795	CcSEcCtD
Methyclothiazide—Malnutrition—Topiramate—epilepsy syndrome	8.71e-05	0.000795	CcSEcCtD
Methyclothiazide—Headache—Oxcarbazepine—epilepsy syndrome	8.66e-05	0.00079	CcSEcCtD
Methyclothiazide—Nausea—Zonisamide—epilepsy syndrome	8.63e-05	0.000787	CcSEcCtD
Methyclothiazide—Dizziness—Lamotrigine—epilepsy syndrome	8.48e-05	0.000774	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Gabapentin—epilepsy syndrome	8.45e-05	0.000771	CcSEcCtD
Methyclothiazide—Vomiting—Carbamazepine—epilepsy syndrome	8.44e-05	0.00077	CcSEcCtD
Methyclothiazide—Muscle spasms—Topiramate—epilepsy syndrome	8.37e-05	0.000764	CcSEcCtD
Methyclothiazide—Rash—Carbamazepine—epilepsy syndrome	8.37e-05	0.000763	CcSEcCtD
Methyclothiazide—Dermatitis—Carbamazepine—epilepsy syndrome	8.36e-05	0.000763	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	8.32e-05	0.0011	CbGpPWpGaD
Methyclothiazide—Nausea—Clonazepam—epilepsy syndrome	8.31e-05	0.000758	CcSEcCtD
Methyclothiazide—Headache—Carbamazepine—epilepsy syndrome	8.31e-05	0.000758	CcSEcCtD
Methyclothiazide—Paraesthesia—Pregabalin—epilepsy syndrome	8.27e-05	0.000755	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.27e-05	0.000755	CcSEcCtD
Methyclothiazide—Nausea—Phenytoin—epilepsy syndrome	8.26e-05	0.000753	CcSEcCtD
Methyclothiazide—Nausea—Oxcarbazepine—epilepsy syndrome	8.21e-05	0.000749	CcSEcCtD
Methyclothiazide—Vision blurred—Topiramate—epilepsy syndrome	8.21e-05	0.000749	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	8.16e-05	0.00108	CbGpPWpGaD
Methyclothiazide—Vomiting—Lamotrigine—epilepsy syndrome	8.16e-05	0.000744	CcSEcCtD
Methyclothiazide—Urticaria—Valproic Acid—epilepsy syndrome	8.1e-05	0.000739	CcSEcCtD
Methyclothiazide—CA4—Metabolism—CA13—epilepsy syndrome	8.09e-05	0.00107	CbGpPWpGaD
Methyclothiazide—Rash—Lamotrigine—epilepsy syndrome	8.09e-05	0.000738	CcSEcCtD
Methyclothiazide—Dermatitis—Lamotrigine—epilepsy syndrome	8.08e-05	0.000737	CcSEcCtD
Methyclothiazide—Body temperature increased—Valproic Acid—epilepsy syndrome	8.06e-05	0.000735	CcSEcCtD
Methyclothiazide—Anorexia—Gabapentin—epilepsy syndrome	8.05e-05	0.000735	CcSEcCtD
Methyclothiazide—Headache—Lamotrigine—epilepsy syndrome	8.04e-05	0.000733	CcSEcCtD
Methyclothiazide—Decreased appetite—Pregabalin—epilepsy syndrome	8.01e-05	0.000731	CcSEcCtD
Methyclothiazide—Agitation—Topiramate—epilepsy syndrome	8e-05	0.00073	CcSEcCtD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	7.99e-05	0.00106	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	7.97e-05	0.00106	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	7.97e-05	0.00106	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	7.97e-05	0.00106	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	7.97e-05	0.00106	CbGpPWpGaD
Methyclothiazide—Nausea—Carbamazepine—epilepsy syndrome	7.88e-05	0.000719	CcSEcCtD
Methyclothiazide—Constipation—Pregabalin—epilepsy syndrome	7.88e-05	0.000719	CcSEcCtD
Methyclothiazide—Vertigo—Topiramate—epilepsy syndrome	7.83e-05	0.000714	CcSEcCtD
Methyclothiazide—Leukopenia—Topiramate—epilepsy syndrome	7.8e-05	0.000711	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	7.79e-05	0.00103	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CA13—epilepsy syndrome	7.76e-05	0.00103	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	7.67e-05	0.00102	CbGpPWpGaD
Methyclothiazide—Nausea—Lamotrigine—epilepsy syndrome	7.62e-05	0.000695	CcSEcCtD
Methyclothiazide—Paraesthesia—Gabapentin—epilepsy syndrome	7.59e-05	0.000692	CcSEcCtD
Methyclothiazide—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.51e-05	0.000685	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	7.46e-05	0.00099	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CA13—epilepsy syndrome	7.44e-05	0.000987	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	7.41e-05	0.000983	CbGpPWpGaD
Methyclothiazide—Decreased appetite—Gabapentin—epilepsy syndrome	7.35e-05	0.00067	CcSEcCtD
Methyclothiazide—Urticaria—Pregabalin—epilepsy syndrome	7.32e-05	0.000668	CcSEcCtD
Methyclothiazide—Asthenia—Valproic Acid—epilepsy syndrome	7.31e-05	0.000667	CcSEcCtD
Methyclothiazide—Body temperature increased—Pregabalin—epilepsy syndrome	7.28e-05	0.000664	CcSEcCtD
Methyclothiazide—Constipation—Gabapentin—epilepsy syndrome	7.23e-05	0.000659	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	7.19e-05	0.000953	CbGpPWpGaD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	7.17e-05	0.000952	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—BCL2—epilepsy syndrome	7.12e-05	0.000944	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	7.07e-05	0.000938	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Valproic Acid—epilepsy syndrome	6.97e-05	0.000636	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	6.97e-05	0.000924	CbGpPWpGaD
Methyclothiazide—Thrombocytopenia—Topiramate—epilepsy syndrome	6.96e-05	0.000635	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	6.94e-05	0.000921	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	6.94e-05	0.000921	CbGpPWpGaD
Methyclothiazide—Hypersensitivity—Pregabalin—epilepsy syndrome	6.79e-05	0.000619	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	6.78e-05	0.000899	CbGpPWpGaD
Methyclothiazide—Anorexia—Topiramate—epilepsy syndrome	6.78e-05	0.000618	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—PTGS2—epilepsy syndrome	6.76e-05	0.000897	CbGpPWpGaD
Methyclothiazide—Dizziness—Valproic Acid—epilepsy syndrome	6.74e-05	0.000615	CcSEcCtD
Methyclothiazide—Urticaria—Gabapentin—epilepsy syndrome	6.71e-05	0.000612	CcSEcCtD
Methyclothiazide—Body temperature increased—Gabapentin—epilepsy syndrome	6.68e-05	0.000609	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	6.65e-05	0.000883	CbGpPWpGaD
Methyclothiazide—Asthenia—Pregabalin—epilepsy syndrome	6.61e-05	0.000603	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	6.52e-05	0.000866	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	6.51e-05	0.000864	CbGpPWpGaD
Methyclothiazide—Vomiting—Valproic Acid—epilepsy syndrome	6.48e-05	0.000591	CcSEcCtD
Methyclothiazide—Rash—Valproic Acid—epilepsy syndrome	6.43e-05	0.000586	CcSEcCtD
Methyclothiazide—Dermatitis—Valproic Acid—epilepsy syndrome	6.42e-05	0.000586	CcSEcCtD
Methyclothiazide—Headache—Valproic Acid—epilepsy syndrome	6.39e-05	0.000582	CcSEcCtD
Methyclothiazide—Paraesthesia—Topiramate—epilepsy syndrome	6.38e-05	0.000582	CcSEcCtD
Methyclothiazide—Diarrhoea—Pregabalin—epilepsy syndrome	6.3e-05	0.000575	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	6.3e-05	0.000836	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	6.3e-05	0.000836	CbGpPWpGaD
Methyclothiazide—Hypersensitivity—Gabapentin—epilepsy syndrome	6.23e-05	0.000568	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	6.19e-05	0.000821	CbGpPWpGaD
Methyclothiazide—Decreased appetite—Topiramate—epilepsy syndrome	6.18e-05	0.000564	CcSEcCtD
Methyclothiazide—CA4—Metabolism—L2HGDH—epilepsy syndrome	6.13e-05	0.000814	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PDXK—epilepsy syndrome	6.13e-05	0.000814	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—FAR1—epilepsy syndrome	6.13e-05	0.000814	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CERS1—epilepsy syndrome	6.13e-05	0.000814	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ADK—epilepsy syndrome	6.13e-05	0.000814	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GLUD1—epilepsy syndrome	6.13e-05	0.000814	CbGpPWpGaD
Methyclothiazide—Dizziness—Pregabalin—epilepsy syndrome	6.09e-05	0.000556	CcSEcCtD
Methyclothiazide—Constipation—Topiramate—epilepsy syndrome	6.08e-05	0.000555	CcSEcCtD
Methyclothiazide—Asthenia—Gabapentin—epilepsy syndrome	6.06e-05	0.000553	CcSEcCtD
Methyclothiazide—Nausea—Valproic Acid—epilepsy syndrome	6.05e-05	0.000552	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	6.04e-05	0.000801	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GLUD1—epilepsy syndrome	5.88e-05	0.00078	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CERS1—epilepsy syndrome	5.88e-05	0.00078	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ADK—epilepsy syndrome	5.88e-05	0.00078	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PDXK—epilepsy syndrome	5.88e-05	0.00078	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—FAR1—epilepsy syndrome	5.88e-05	0.00078	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—L2HGDH—epilepsy syndrome	5.88e-05	0.00078	CbGpPWpGaD
Methyclothiazide—Vomiting—Pregabalin—epilepsy syndrome	5.86e-05	0.000534	CcSEcCtD
Methyclothiazide—Rash—Pregabalin—epilepsy syndrome	5.81e-05	0.00053	CcSEcCtD
Methyclothiazide—Dermatitis—Pregabalin—epilepsy syndrome	5.8e-05	0.00053	CcSEcCtD
Methyclothiazide—Diarrhoea—Gabapentin—epilepsy syndrome	5.78e-05	0.000527	CcSEcCtD
Methyclothiazide—Headache—Pregabalin—epilepsy syndrome	5.77e-05	0.000527	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	5.66e-05	0.000751	CbGpPWpGaD
Methyclothiazide—Urticaria—Topiramate—epilepsy syndrome	5.65e-05	0.000515	CcSEcCtD
Methyclothiazide—CA1—Metabolism—PDXK—epilepsy syndrome	5.64e-05	0.000748	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—FAR1—epilepsy syndrome	5.64e-05	0.000748	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ADK—epilepsy syndrome	5.64e-05	0.000748	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GLUD1—epilepsy syndrome	5.64e-05	0.000748	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—L2HGDH—epilepsy syndrome	5.64e-05	0.000748	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CERS1—epilepsy syndrome	5.64e-05	0.000748	CbGpPWpGaD
Methyclothiazide—Body temperature increased—Topiramate—epilepsy syndrome	5.62e-05	0.000513	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	5.62e-05	0.000745	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GAMT—epilepsy syndrome	5.61e-05	0.000744	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—EPM2A—epilepsy syndrome	5.61e-05	0.000744	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PNPO—epilepsy syndrome	5.61e-05	0.000744	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NHLRC1—epilepsy syndrome	5.61e-05	0.000744	CbGpPWpGaD
Methyclothiazide—Dizziness—Gabapentin—epilepsy syndrome	5.59e-05	0.00051	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.51e-05	0.000731	CbGpPWpGaD
Methyclothiazide—Nausea—Pregabalin—epilepsy syndrome	5.47e-05	0.000499	CcSEcCtD
Methyclothiazide—CA2—Metabolism—EPM2A—epilepsy syndrome	5.38e-05	0.000713	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PNPO—epilepsy syndrome	5.38e-05	0.000713	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NHLRC1—epilepsy syndrome	5.38e-05	0.000713	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GAMT—epilepsy syndrome	5.38e-05	0.000713	CbGpPWpGaD
Methyclothiazide—Vomiting—Gabapentin—epilepsy syndrome	5.37e-05	0.00049	CcSEcCtD
Methyclothiazide—Rash—Gabapentin—epilepsy syndrome	5.33e-05	0.000486	CcSEcCtD
Methyclothiazide—Dermatitis—Gabapentin—epilepsy syndrome	5.32e-05	0.000486	CcSEcCtD
Methyclothiazide—Headache—Gabapentin—epilepsy syndrome	5.29e-05	0.000483	CcSEcCtD
Methyclothiazide—Hypersensitivity—Topiramate—epilepsy syndrome	5.24e-05	0.000478	CcSEcCtD
Methyclothiazide—CA4—Metabolism—QDPR—epilepsy syndrome	5.21e-05	0.000692	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PNPO—epilepsy syndrome	5.16e-05	0.000684	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—EPM2A—epilepsy syndrome	5.16e-05	0.000684	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NHLRC1—epilepsy syndrome	5.16e-05	0.000684	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GAMT—epilepsy syndrome	5.16e-05	0.000684	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	5.14e-05	0.000681	CbGpPWpGaD
Methyclothiazide—Asthenia—Topiramate—epilepsy syndrome	5.1e-05	0.000465	CcSEcCtD
Methyclothiazide—Nausea—Gabapentin—epilepsy syndrome	5.02e-05	0.000458	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.01e-05	0.000664	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—QDPR—epilepsy syndrome	5e-05	0.000663	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CA4—epilepsy syndrome	5e-05	0.000663	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—COX3—epilepsy syndrome	4.9e-05	0.00065	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Topiramate—epilepsy syndrome	4.86e-05	0.000444	CcSEcCtD
Methyclothiazide—CA1—Metabolism—CA4—epilepsy syndrome	4.79e-05	0.000636	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—QDPR—epilepsy syndrome	4.79e-05	0.000636	CbGpPWpGaD
Methyclothiazide—Dizziness—Topiramate—epilepsy syndrome	4.7e-05	0.000429	CcSEcCtD
Methyclothiazide—CA2—Metabolism—COX3—epilepsy syndrome	4.7e-05	0.000624	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	4.69e-05	0.000622	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SLC6A8—epilepsy syndrome	4.65e-05	0.000617	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—KCNB1—epilepsy syndrome	4.65e-05	0.000617	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CACNA2D2—epilepsy syndrome	4.65e-05	0.000617	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PFKL—epilepsy syndrome	4.65e-05	0.000617	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SLCO1A2—epilepsy syndrome	4.65e-05	0.000617	CbGpPWpGaD
Methyclothiazide—Vomiting—Topiramate—epilepsy syndrome	4.52e-05	0.000412	CcSEcCtD
Methyclothiazide—CA1—Metabolism—COX3—epilepsy syndrome	4.51e-05	0.000598	CbGpPWpGaD
Methyclothiazide—Rash—Topiramate—epilepsy syndrome	4.48e-05	0.000409	CcSEcCtD
Methyclothiazide—Dermatitis—Topiramate—epilepsy syndrome	4.48e-05	0.000408	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.47e-05	0.000593	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SLCO1A2—epilepsy syndrome	4.46e-05	0.000591	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—KCNB1—epilepsy syndrome	4.46e-05	0.000591	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CACNA2D2—epilepsy syndrome	4.46e-05	0.000591	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PFKL—epilepsy syndrome	4.46e-05	0.000591	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SLC6A8—epilepsy syndrome	4.46e-05	0.000591	CbGpPWpGaD
Methyclothiazide—Headache—Topiramate—epilepsy syndrome	4.45e-05	0.000406	CcSEcCtD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	4.35e-05	0.000577	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—KCNB1—epilepsy syndrome	4.27e-05	0.000567	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CACNA2D2—epilepsy syndrome	4.27e-05	0.000567	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SLCO1A2—epilepsy syndrome	4.27e-05	0.000567	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PFKL—epilepsy syndrome	4.27e-05	0.000567	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SLC6A8—epilepsy syndrome	4.27e-05	0.000567	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	4.26e-05	0.000565	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ATIC—epilepsy syndrome	4.25e-05	0.000564	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NEU1—epilepsy syndrome	4.25e-05	0.000564	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—UPB1—epilepsy syndrome	4.25e-05	0.000564	CbGpPWpGaD
Methyclothiazide—Nausea—Topiramate—epilepsy syndrome	4.22e-05	0.000385	CcSEcCtD
Methyclothiazide—CA4—Metabolism—HSD17B4—epilepsy syndrome	4.09e-05	0.000543	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NEU1—epilepsy syndrome	4.08e-05	0.000541	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—UPB1—epilepsy syndrome	4.08e-05	0.000541	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ATIC—epilepsy syndrome	4.08e-05	0.000541	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.06e-05	0.000539	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PPP1R3C—epilepsy syndrome	3.95e-05	0.000524	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GBE1—epilepsy syndrome	3.95e-05	0.000524	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	3.95e-05	0.000524	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HSD17B4—epilepsy syndrome	3.92e-05	0.00052	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NEU1—epilepsy syndrome	3.91e-05	0.000518	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—UPB1—epilepsy syndrome	3.91e-05	0.000518	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ATIC—epilepsy syndrome	3.91e-05	0.000518	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GBE1—epilepsy syndrome	3.79e-05	0.000503	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PPP1R3C—epilepsy syndrome	3.79e-05	0.000503	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HSD17B4—epilepsy syndrome	3.76e-05	0.000499	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ASAH1—epilepsy syndrome	3.72e-05	0.000493	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.68e-05	0.000488	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.65e-05	0.000484	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PPP1R3C—epilepsy syndrome	3.63e-05	0.000482	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GBE1—epilepsy syndrome	3.63e-05	0.000482	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—STXBP1—epilepsy syndrome	3.61e-05	0.000479	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ASAH1—epilepsy syndrome	3.56e-05	0.000473	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.53e-05	0.000468	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NT5E—epilepsy syndrome	3.52e-05	0.000467	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALAD—epilepsy syndrome	3.52e-05	0.000467	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—STXBP1—epilepsy syndrome	3.46e-05	0.00046	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ASAH1—epilepsy syndrome	3.41e-05	0.000453	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NT5E—epilepsy syndrome	3.38e-05	0.000448	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALAD—epilepsy syndrome	3.38e-05	0.000448	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CACNA1A—epilepsy syndrome	3.36e-05	0.000446	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALDH7A1—epilepsy syndrome	3.36e-05	0.000446	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.34e-05	0.000443	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—STXBP1—epilepsy syndrome	3.32e-05	0.000441	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.31e-05	0.000439	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ST3GAL3—epilepsy syndrome	3.29e-05	0.000436	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NT5E—epilepsy syndrome	3.24e-05	0.000429	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALAD—epilepsy syndrome	3.24e-05	0.000429	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CACNA1A—epilepsy syndrome	3.22e-05	0.000427	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALDH7A1—epilepsy syndrome	3.22e-05	0.000427	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ADSL—epilepsy syndrome	3.22e-05	0.000427	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.21e-05	0.000425	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GLUL—epilepsy syndrome	3.16e-05	0.000419	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ST3GAL3—epilepsy syndrome	3.15e-05	0.000418	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CACNA1D—epilepsy syndrome	3.1e-05	0.000411	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALDH7A1—epilepsy syndrome	3.09e-05	0.00041	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CACNA1A—epilepsy syndrome	3.09e-05	0.00041	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ADSL—epilepsy syndrome	3.09e-05	0.00041	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GLUL—epilepsy syndrome	3.03e-05	0.000402	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ST3GAL3—epilepsy syndrome	3.02e-05	0.000401	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CACNA1D—epilepsy syndrome	2.97e-05	0.000394	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ADSL—epilepsy syndrome	2.96e-05	0.000393	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GLUL—epilepsy syndrome	2.9e-05	0.000385	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—TXNRD1—epilepsy syndrome	2.9e-05	0.000385	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CACNA1D—epilepsy syndrome	2.85e-05	0.000378	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—AQP1—epilepsy syndrome	2.82e-05	0.000374	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—TXNRD1—epilepsy syndrome	2.78e-05	0.000369	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—AQP1—epilepsy syndrome	2.7e-05	0.000358	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—TXNRD1—epilepsy syndrome	2.67e-05	0.000354	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—AQP1—epilepsy syndrome	2.59e-05	0.000343	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CHRM3—epilepsy syndrome	2.55e-05	0.000338	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—KCNJ11—epilepsy syndrome	2.55e-05	0.000338	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—KCNJ11—epilepsy syndrome	2.44e-05	0.000324	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CHRM3—epilepsy syndrome	2.44e-05	0.000324	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—KCNJ11—epilepsy syndrome	2.34e-05	0.00031	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CHRM3—epilepsy syndrome	2.34e-05	0.00031	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.21e-05	0.000293	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ABCG2—epilepsy syndrome	2.08e-05	0.000275	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP2C19—epilepsy syndrome	2.02e-05	0.000268	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP11A1—epilepsy syndrome	2.01e-05	0.000267	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.01e-05	0.000266	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ABCG2—epilepsy syndrome	1.99e-05	0.000264	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP2C19—epilepsy syndrome	1.94e-05	0.000257	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP11A1—epilepsy syndrome	1.93e-05	0.000256	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ABCG2—epilepsy syndrome	1.91e-05	0.000253	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP2C19—epilepsy syndrome	1.86e-05	0.000247	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP11A1—epilepsy syndrome	1.85e-05	0.000245	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP2D6—epilepsy syndrome	1.81e-05	0.000241	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP2D6—epilepsy syndrome	1.74e-05	0.000231	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ADRA2A—epilepsy syndrome	1.73e-05	0.000229	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—BCHE—epilepsy syndrome	1.72e-05	0.000228	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP2D6—epilepsy syndrome	1.67e-05	0.000221	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ADRA2A—epilepsy syndrome	1.66e-05	0.00022	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—BCHE—epilepsy syndrome	1.65e-05	0.000219	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SLC2A1—epilepsy syndrome	1.64e-05	0.000218	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PLCB1—epilepsy syndrome	1.62e-05	0.000215	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—TH—epilepsy syndrome	1.62e-05	0.000215	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ADRA2A—epilepsy syndrome	1.59e-05	0.000211	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—BCHE—epilepsy syndrome	1.58e-05	0.00021	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SLC2A1—epilepsy syndrome	1.57e-05	0.000209	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PLCB1—epilepsy syndrome	1.56e-05	0.000206	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—TH—epilepsy syndrome	1.55e-05	0.000206	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SLC2A1—epilepsy syndrome	1.51e-05	0.0002	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PLCB1—epilepsy syndrome	1.49e-05	0.000198	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—TH—epilepsy syndrome	1.49e-05	0.000197	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HMOX1—epilepsy syndrome	1.35e-05	0.000179	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CAT—epilepsy syndrome	1.33e-05	0.000177	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ABCB1—epilepsy syndrome	1.3e-05	0.000172	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HMOX1—epilepsy syndrome	1.29e-05	0.000172	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CAT—epilepsy syndrome	1.28e-05	0.000169	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ABCB1—epilepsy syndrome	1.24e-05	0.000165	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HMOX1—epilepsy syndrome	1.24e-05	0.000165	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CAT—epilepsy syndrome	1.22e-05	0.000162	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GPX1—epilepsy syndrome	1.2e-05	0.00016	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ABCB1—epilepsy syndrome	1.19e-05	0.000158	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GPX1—epilepsy syndrome	1.15e-05	0.000153	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GPX1—epilepsy syndrome	1.11e-05	0.000147	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—AGT—epilepsy syndrome	1.06e-05	0.00014	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—APOE—epilepsy syndrome	1.03e-05	0.000137	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—AGT—epilepsy syndrome	1.01e-05	0.000134	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—APOE—epilepsy syndrome	9.92e-06	0.000132	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—AGT—epilepsy syndrome	9.71e-06	0.000129	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—APOE—epilepsy syndrome	9.51e-06	0.000126	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—POMC—epilepsy syndrome	8.89e-06	0.000118	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—POMC—epilepsy syndrome	8.52e-06	0.000113	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—POMC—epilepsy syndrome	8.17e-06	0.000108	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALB—epilepsy syndrome	8.1e-06	0.000108	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALB—epilepsy syndrome	7.77e-06	0.000103	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALB—epilepsy syndrome	7.45e-06	9.88e-05	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PTGS2—epilepsy syndrome	7.09e-06	9.41e-05	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PTGS2—epilepsy syndrome	6.8e-06	9.02e-05	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PTGS2—epilepsy syndrome	6.52e-06	8.65e-05	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—AKT1—epilepsy syndrome	3.56e-06	4.73e-05	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—AKT1—epilepsy syndrome	3.42e-06	4.53e-05	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—AKT1—epilepsy syndrome	3.28e-06	4.35e-05	CbGpPWpGaD
